Sinha B, Ghosal S
For reference on class-related adverse effects and warnings, the Summary of Product Characteristics (SmPC) for approved GLP-1 and dual GIP/GLP-1 receptor agonists including Wegovy (semaglutide) and Mounjaro (tirzepatide) are available on the Electronic Medicines Compendium (www.medicines.org.uk/emc)
Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, et al
H., Sun, Q., Savenkov, O., Louka, C., Liu, C., et al
We therefore recommend using barrier contraception prior to conception. Couldwell emphasizes that these recommendations are based on a review of the research thus far, but with so many unknowns, recommendations may change
A menopause clinician breaks it down The poll results are inand you delivered